Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

Clinical trial NCT06325709 · RECRUITING

Trial details

NCT number: NCT06325709
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Granulomatous Disease (CGD)X-Linked Chronic Granulomatous Disease

Start date: 2024-04-17
Primary completion: 2032-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.